ReviewBioengineering (Basel, Switzerland)2026
Advancing Microplastic and Nanoplastic Toxicity Assessment: Insights from Human Organoid Models.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathogenesis of Micro/Nanoplastics in Mammalian Systems: Gut to Systemic Multi-Organ Dysfunction.Research (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Evidence has demonstrated that microplastics (MPs) and nanoplastics (NPs) exerted toxic effects on animal models; our understanding of their potential toxicity to human health remains limited due to the lack of human-relevant in vitro models. Human stem cell-derived organoids are sophisticated and multicellular structures that could effectively mimic the key features of native organs and tissues. To date, human organoids have been widely used in toxicology. This study reviews the current application of human organoids in the toxicity assessment of MPs and NPs. Current limitations and future perspectives are discussed. Cutting-edge technologies combined with organoids are expected to provide new insights for illustrating the potential toxicity of MPs and NPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.